Secured ten new fully-issued patents related to hypertension treatment during last 12 months, bringing global issued patent estate total for this condition to 120 patentsPatent estate covering ...

The Family Heart Foundation, a leading research and advocacy organization focused on the role of lipids in cardiovascular ...

Enables Lantheus to focus on innovative radiopharmaceuticals, while maximizing the value of its SPECT business SHINE will acquire products TechneLite®, NEUROLITE®, Xenon Xe-133 Gas, and Cardiolite® ...

Study showed that every increase in Lp(a) is associated with increased risk of a cardiovascular event; individuals with the highest levels (>300 ...

The heart squeezes blood by ‘pumping' it to every nook and corner of the body. If blood flow gets suddenly interrupted owing ...

For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial.

DUBLIN and BRIDGEWATER, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the first quarter of 2025.